The table below shows NEOGENOMICS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$186.67M
$187.80M
$181.33M
$168.03M
$167.82M
$164.50M
Cost of revenue
$105.81M
$107.35M
$104.07M
$94.79M
$92.94M
$92.01M
Gross profit
$80.86M
$80.45M
$77.26M
$73.25M
$74.88M
$72.49M
R&D
$9.53M
$8.69M
$9.02M
$10.18M
$7.68M
$7.89M
NEO annual revenue (10-K history)
NEOGENOMICS INC reported annual revenue of $727.33M for fiscal year 2025. That is up 10.1% from $660.57M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $231.81M (FY 2016) to $727.33M. Figures come from the company's audited annual reports as filed with the SEC.
